Abstract
A procedure for preparing 1-(2-hydroxy-3-[18F]fluoropropyl)-2-nitroimidazole ([18F]fluoromisonidazole, [18F]FMISO) on a commercially available GE TracerLAB Fx F-N synthesis module was developed. The product obtained meets all the requirements of the European Pharmacopoeia (8th ed.) for clinical use. Its decay-corrected radiochemical yield is 59 ± 4% (n = 5).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have